The growing demand for precise immunological research and therapeutic design has spurred significant improvements in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using multiple expression platforms, including bacterial hosts, animal cell cultures, and baculovirus